- BCAM Launches New Collaboration Initiative To Celebrate 20th Anniversary
BCAM Launches New Collaboration Initiative To Celebrate 20th Anniversary
To celebrate its 20th anniversary year, and in recognition of a commitment to connectivity and patient safety, the British College of Aesthetic Medicine (BCAM) has launched a new initiative to engage with other organisations in its sector.
BCAM already works closely with the Department of Health and Social Care (DHSC), sharing data that informs government decision-making, and is involved in consultations with the Medicines and Healthcare products Regulatory Agency (MHRA).
The BCAM Stakeholder Engagement Initiative is a further step towards bringing together all of those involved in Aesthetic Medicine in the UK to share good practice, promote patient safety and lobby for better regulation of treatments.
BCAM President Dr Uliana Gout said: “For the past 20 years BCAM has been working to ensure patient safety is a priority in Aesthetic Medicine and to highlight any issues raised by our annual audit of members’ clinical activity to the DHSC.
“Over the past few months, we have worked more closely with others including the MHRA, JCCP and BACN and we recognise the benefit of this collaborative approach. We have therefore decided to launch an initiative to bring together stakeholders for regular meetings where we can share information and work together on improving standards, increasing public safety and raising awareness of the importance of consulting healthcare professionals for aesthetic treatments.”
BCAM supported Laura Trott MP’s Botulinum Toxin and Cosmetic Fillers (Children) Bill 2019-21 which became law on 1 October and is keen to work with stakeholders on other key issues including the regulation of dermal filler treatments.
BCAM Trustee Dr John Elder, the College’s representative on the Joint Council for Cosmetic Practitioners (JCCP), said: “Working collaboratively has huge benefits for BCAM and the Aesthetic Medicine sector as a whole – together we can pool our knowledge and resources and campaign for better regulation and public information.”
Dr John Curran, who heads BCAM’s Regulatory, Ethics and Professional Standards Committee, said: “The demand for aesthetic treatments is growing in the UK and public safety must be a priority. This initiative will bring together expertise from across the spectrum of organisations representing healthcare professionals working in Aesthetic Medicine.”
View other News